|
Altria Group, Inc. announced this week that the U.S. Food and Drug Administration (FDA) authorized the marketing of the IQOS tobacco heating system as a modified risk tobacco product with a reduced exposure claim.
“We’re delighted that the FDA authorized IQOS to be marketed as a modified-risk tobacco product," said Billy Gifford, CEO of Altria. "This authorization gives PM USA an opportunity to communicate additional benefits of switching to IQOS and this decision is an important step for adult smokers. Our 10-year vision is to responsibly lead the transition of adult smokers to a non-combustible future. IQOS is a key part of that future as we develop our portfolio of FDA-authorized, non-combustible products and actively switch adult smokers to them."
For more information, read the company's official release.
|